BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17848299)

  • 1. Antiangiogenesis and vascular endothelial growth factor/vascular endothelial growth factor receptor targeting as part of a combined-modality approach to the treatment of cancer.
    O'Reilly MS
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S64-6. PubMed ID: 17848299
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiangiogenic therapy and surgical practice.
    John AR; Bramhall SR; Eggo MC
    Br J Surg; 2008 Mar; 95(3):281-93. PubMed ID: 18278790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting small molecules in cancer.
    Wanebo HJ; Berz D; Mega A
    Cancer Treat Res; 2007; 135():239-55. PubMed ID: 17953421
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiangiogenesis, anti-VEGF(R) and outlook.
    Petersen I
    Recent Results Cancer Res; 2007; 176():189-99. PubMed ID: 17607926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating the tumor microenvironment to improve radiotherapy.
    Maity A
    Retina; 2009 Jun; 29(6 Suppl):S32-3. PubMed ID: 19553796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New molecular target of cancer therapy--angiogenesis regulator VEGF].
    Toi M; Ueno T; Tominaga T
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2202-6. PubMed ID: 9422062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.
    Roukos DH; Tzakos A; Zografos G
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1413-6. PubMed ID: 19828000
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiogenesis: novel and basic science insights and human therapy - keystone symposium.
    Iruela-Arispe L
    IDrugs; 2004 Feb; 7(2):111-3. PubMed ID: 15057650
    [No Abstract]   [Full Text] [Related]  

  • 9. [Are antiangiogenic antibodies universal for solid tumor?].
    Ray-Coquard I; Bachelot T; Saba C; Confavreux C; Brantus JF; Rustam F; Ghesquière H; Sebban C; Biron P; Guastalla JP; Blay JY
    Bull Cancer; 2007 Jul; 94 Spec No():S191-6. PubMed ID: 17846004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; a review.
    Eskens FA; Verweij J
    Eur J Cancer; 2006 Dec; 42(18):3127-39. PubMed ID: 17098419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fight against cancer: the next round.
    Doherty M
    Drug Discov Today; 2004 Nov; 9(22):947-8. PubMed ID: 15539135
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging tumor angiogenesis.
    Red-Horse K; Ferrara N
    J Clin Invest; 2006 Oct; 116(10):2585-7. PubMed ID: 17016553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of angiogenesis by proteins, peptides and "small molecules"].
    Jayson G; Armand JP; Berdel WE
    Onkologie; 2005 Oct; 28 Suppl 4():29-34. PubMed ID: 16205103
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts.
    Lund EL; Bastholm L; Kristjansen PE
    Clin Cancer Res; 2000 Mar; 6(3):971-8. PubMed ID: 10741723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Stroma, Tumor Blood Vessels, and Antiangiogenesis Therapy.
    Dvorak HF
    Cancer J; 2015; 21(4):237-43. PubMed ID: 26222073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten years of anti-vascular endothelial growth factor therapy.
    Ferrara N; Adamis AP
    Nat Rev Drug Discov; 2016 Jun; 15(6):385-403. PubMed ID: 26775688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor as a therapeutic target in cancer.
    Bergsland EK
    Am J Health Syst Pharm; 2004 Nov; 61(21 Suppl 5):S4-11. PubMed ID: 15552621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic strategies in neuroblastoma.
    Ribatti D; Ponzoni M
    Cancer Treat Rev; 2005 Feb; 31(1):27-34. PubMed ID: 15707702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor receptors: expression and function in solid tumors.
    Wey JS; Stoeltzing O; Ellis LM
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):37-45. PubMed ID: 16163158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.